Methylprednisolone hemisuccinate
- Generic Name
- Methylprednisolone hemisuccinate
- Brand Names
- Solu-medrol
- Drug Type
- Small Molecule
- Chemical Formula
- C26H34O8
- CAS Number
- 2921-57-5
- Unique Ingredient Identifier
- 5GMR90S4KN
- Background
A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
- Associated Conditions
- Acute Gouty Arthritis, Ankylosing Spondylitis (AS), Berylliosis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatitis bullous, Dermatomyositis (DM), Edema of the cerebrum, Hypercalcemia of Malignancy, Immune Thrombocytopenia (ITP), Leukemias, Lymphoma, Multiple sclerosis exacerbation, Mycosis Fungoides (MF), Ophthalmia, Sympathetic, Pemphigus, Polymyositis, Primary adrenocortical insufficiency, Psoriatic Arthritis, Pure Red Cell Aplasia, Refractory Uveitis, Regional Enteritis, Rheumatoid Arthritis, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Fulminating Pulmonary Tuberculosis, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Severe Allergic Reactions, Symptomatic Sarcoidosis
- Associated Therapies
- Palliative Treatment
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 30
- Registration Number
- NCT05842681
- Locations
- 🇪🇬
Assiut university-Faculty of Medicine, Assiut, Egypt
Safety and Clinical Activity of Itolizumab in aGVHD
- Conditions
- Interventions
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT05823675
- Locations
- 🇨🇳
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy
- First Posted Date
- 2023-03-31
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Medical University of Sofia
- Target Recruit Count
- 62
- Registration Number
- NCT05793359
- Locations
- 🇧🇬
University Hospital of Endocrinology, Sofia, Bulgaria
Morton's Neuroma: Manipulation Versus Steroid Injection
- Conditions
- Interventions
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Dundee Podiatry Clinic
- Target Recruit Count
- 62
- Registration Number
- NCT05707572
- Locations
- 🇬🇧
Podiatry Department NHS Lothian, Edinburgh, Lothian, United Kingdom
A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 74
- Registration Number
- NCT05704049
- Locations
- 🇦🇺
Investigational Site Number : 0360002, Wollongong, New South Wales, Australia
🇧🇷Hospital Mae de Deus Site Number : 0760002, Porto Alegre, Rio Grande Do Sul, Brazil
🇦🇺Investigational Site Number : 0360001, Fitzroy, Victoria, Australia
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Fen Li
- Target Recruit Count
- 30
- Registration Number
- NCT05666336
- Locations
- 🇨🇳
Department of Rheumatology and Immunology, Xiangya Second Hospital, Central South University, Changsha, Hunan, China
Distal Radius Steroid
- Conditions
- Interventions
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Indiana Hand to Shoulder Center
- Target Recruit Count
- 30
- Registration Number
- NCT05655130
- Locations
- 🇺🇸
Indiana Hand to Shoulder Center, Indianapolis, Indiana, United States
Follow-up and Steroid Treatment Results in Intussusception
- First Posted Date
- 2022-12-07
- Last Posted Date
- 2022-12-12
- Lead Sponsor
- Baskent University
- Target Recruit Count
- 120
- Registration Number
- NCT05640375
- Locations
- 🇹🇷
Baskent University, Ankara, Turkey
A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 80
- Registration Number
- NCT05627557
- Locations
- 🇺🇸
Memorial Healthcare System, Hollywood, Florida, United States
🇺🇸Children's Healthcare of Atlanta Center for Advanced Pediatrics, Atlanta, Georgia, United States
🇺🇸Nicklaus Children's Hospital, Miami, Florida, United States
Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Qin Ning
- Target Recruit Count
- 350
- Registration Number
- NCT05604859
- Locations
- 🇨🇳
Guangshui First Peoples Hospital, Guangshui, Hubei, China
🇨🇳Huanggang Central Hospital, Huanggang, Hubei, China
🇨🇳Luotian County Peoples Hospital, Huanggang, Hubei, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.